cache/735faaebebaf4346582a76b1ba7d3e2f07f7499a5cbba62d37c43c9a1f5f0e89

COM:SANTEN

Santen Pharmaceutical Co., Ltd

  • Stock

Last Close

1,765.00

25/09 06:15

Market Cap

650.87B

Beta: -

Volume Today

1.42M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
148.66B
-
161.83B
8.86%
195.29B
20.68%
199.10B
1.95%
224.94B
12.98%
234.03B
4.04%
241.56B
3.22%
249.60B
3.33%
266.26B
6.67%
279.04B
4.80%
301.96B
8.22%
cost of revenue
58.10B
-
56.37B
2.98%
72.83B
29.19%
74.97B
2.93%
86.38B
15.22%
90.76B
5.08%
94.83B
4.48%
98.22B
3.57%
109.67B
11.66%
112.95B
2.99%
132.73B
17.51%
gross profit
90.56B
-
105.46B
16.45%
122.46B
16.12%
124.13B
1.36%
138.56B
11.63%
143.26B
3.39%
146.72B
2.42%
151.38B
3.18%
156.59B
3.44%
166.09B
6.07%
169.24B
1.90%
selling and marketing expenses
general and administrative expenses
48.89B
-
59.41B
21.50%
62.19B
4.69%
68.79B
10.60%
71.27B
3.61%
73.36B
2.93%
79.55B
8.44%
84.50B
6.22%
96.26B
13.91%
selling general and administrative expenses
48.89B
-
59.41B
21.50%
62.19B
4.69%
68.79B
10.60%
71.27B
3.61%
73.36B
2.93%
79.55B
8.44%
84.50B
6.22%
96.26B
13.91%
91.53B
4.91%
research and development expenses
17.48B
-
19.99B
14.38%
22.79B
13.99%
24.40B
7.07%
23.76B
2.62%
23.34B
1.76%
24.11B
3.30%
26.38B
9.39%
28.30B
7.28%
25.42B
10.18%
other expenses
154M
-
3.71B
2,311.69%
-37.11B
1,099.27%
6.67B
117.98%
6.69B
0.22%
3.13B
53.16%
16.49B
426.44%
34.80B
111.07%
9.82B
71.77%
cost and expenses
121.25B
-
126.46B
4.30%
115.11B
8.97%
166.62B
44.74%
186.25B
11.78%
188.93B
1.44%
208.02B
10.11%
236.69B
13.78%
230.37B
2.67%
282.13B
22.47%
249.67B
11.50%
operating expenses
63.14B
-
70.08B
10.99%
42.28B
39.67%
91.65B
116.76%
99.87B
8.97%
98.16B
1.71%
113.19B
15.31%
138.47B
22.33%
120.70B
12.83%
169.18B
40.16%
116.94B
30.87%
interest expense
5M
-
279M
5,480%
1.49B
434.77%
1.56B
4.89%
434M
72.27%
2.88B
563.82%
2.39B
16.94%
1.49B
37.82%
1.21B
18.75%
1.50B
23.99%
2.66B
77.72%
ebitda
32.02B
-
43.10B
34.61%
90.30B
109.51%
43.27B
52.08%
50.59B
16.92%
56.97B
12.60%
51.06B
10.37%
30.67B
39.92%
53.88B
75.65%
12.95B
75.97%
70.47B
444.22%
operating income
27.41B
-
35.37B
29.04%
80.18B
126.66%
32.48B
59.49%
38.69B
19.13%
45.10B
16.56%
33.53B
25.64%
12.92B
61.48%
35.89B
177.82%
-3.09B
108.61%
52.29B
1,792.33%
depreciation and amortization
3.93B
-
6.96B
77.23%
9.34B
34.21%
9.88B
5.83%
10.90B
10.26%
10.97B
0.67%
16.57B
51.09%
16.77B
1.18%
17.05B
1.71%
17.25B
1.14%
18.18B
5.39%
total other income expenses net
-521M
-
489M
193.86%
-710M
245.19%
-657M
7.46%
570M
186.76%
1.73B
202.98%
-7.77B
549.86%
-41.09B
428.90%
-259M
99.37%
-41.10B
15,768.34%
-14.84B
63.88%
income before tax
26.89B
-
35.86B
33.35%
79.47B
121.59%
31.82B
59.96%
39.26B
23.38%
43.12B
9.82%
32.09B
25.57%
12.42B
61.30%
35.62B
186.81%
-5.80B
116.28%
37.45B
745.78%
income tax expense
9.78B
-
11.83B
20.93%
26.10B
120.58%
8.77B
66.40%
4B
54.38%
11.17B
179.35%
10.38B
7.13%
5.77B
44.37%
8.43B
45.97%
9.18B
8.98%
3.17B
65.47%
net income
17.11B
-
24.03B
40.46%
53.37B
122.09%
23.05B
56.81%
35.26B
52.95%
31.94B
9.41%
23.62B
26.06%
6.83B
71.08%
27.22B
298.51%
-14.95B
154.92%
26.64B
278.18%
weighted average shs out
412.69M
-
413.06M
0.09%
413.79M
0.18%
410.34M
0.83%
406.42M
0.96%
406.17M
0.06%
399.16M
1.73%
399.46M
0.07%
399.77M
0.08%
387.42M
3.09%
366.89M
5.30%
weighted average shs out dil
413.95M
-
414.86M
0.22%
415.65M
0.19%
411.88M
0.91%
407.87M
0.97%
407.40M
0.12%
400.25M
1.75%
400.39M
0.03%
400.46M
0.02%
387.42M
3.26%
368.14M
4.98%
eps
47.78
-
58.18
21.77%
128.99
121.71%
52.96
58.94%
86.76
63.82%
78.64
9.36%
59.16
24.77%
17.10
71.10%
68.07
298.07%
-38.58
156.68%
72.60
288.18%
epsdiluted
47.63
-
57.93
21.63%
128.41
121.66%
52.76
58.91%
86.45
63.86%
78.41
9.30%
59.01
24.74%
17.06
71.09%
67.97
298.42%
-38.58
156.76%
72.35
287.53%

All numbers in (except ratios and percentages)